Na Gao

5PUBLICATIONS
9CO-AUTHORS
Medical molecular engineering of nucleic acids and proteinsInnate immunityPreventative health careRegenerative medicine (incl. stem cells)Cardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|May 31, 2025
Correction: Nucleos(t)ide analogs continuation is not associated with a lower risk of HBsAg seroreversion following PEG-IFN-induced HBsAg loss.

Na Gao, Haishi Wu, Bin Li

|Mar 20, 2025
Nucleos(t)ide analogs continuation is not associated with a lower risk of HBsAg seroreversion following PEG-IFN-induced HBsAg loss.

Na Gao, Haishi Wu, Bin Li

|Oct 27, 2023
Editorial: HBsAg seroclearance after pegylated interferon treatment-The beginning of the end. Authors' reply.

Na Gao, Guiwen Guan, Qiyi Zhao

|Aug 30, 2023
Integrated HBV DNA and cccDNA maintain transcriptional activity in intrahepatic HBsAg-positive patients with functional cure following PEG-IFN-based therapy.

Na Gao, Guiwen Guan, Ganlin Xu

|Jan 16, 2023
Reduction in Intrahepatic cccDNA and Integration of HBV in Chronic Hepatitis B Patients with a Functional Cure.

Weiqiang Gan, Na Gao, Lin Gu

Pageof 1

Frequent Collaborators

5 joint publications

Zhiliang Gao

4 joint publications

Qiyi Zhao

3 joint publications

Haishi Wu

2 joint publications

Guiwen Guan